Univ Rennes, CHU Rennes, INSERM, LTSI-UMR 1099, F-35000, Rennes, France.
Neonatal Cardiorespiratory Research Unit, Departments of Pediatrics and Physiology, University of Sherbrooke, Sherbrooke, Quebec, Canada.
J Appl Physiol (1985). 2019 Nov 1;127(5):1370-1385. doi: 10.1152/japplphysiol.00994.2018. Epub 2019 Aug 1.
The present study aimed to further unravel the effects of nasal continuous positive airway pressure (nCPAP) on the cardiovascular and respiratory systems in the neonatal period. Six-hour polysomnographic recordings were first performed in seven healthy newborn lambs, aged 2-3 days, without and with nCPAP application at 6 cmHO (nCPAP-6), in randomized order. The effects of nCPAP-6 on heart rate variability, respiratory rate variability, and cardiorespiratory interrelations were analyzed using a semiautomatic signal processing approach applied to ECG and respiration recordings. Thereafter, a cardiorespiratory mathematical model was adapted to the experimental conditions to gain further physiological interpretation and to simulate higher nCPAP levels (8 and 10 cmHO). Results from the signal processing approach suggest that nCPAP-6 applied in newborns with healthy lungs: ) increases heart rate and decreases the time and frequency domain indices of heart rate variability, especially those representing parasympathetic activity, while increasing the complexity of the RR-interval time series; ) prolongs the respiratory cycle and expiration duration and decreases respiratory rate variability; and ) slightly impairs cardiorespiratory interrelations. Model-based analysis revealed that nCPAP-6 increases the heart rate and decreases respiratory sinus arrhythmia amplitude, in association with a reduced parasympathetic efferent activity. These results were accentuated when simulating an increased CPAP level. Overall, our results provide a further understanding of the effects of nCPAP in neonates, in the absence of lung disease. Application of nasal continuous positive airway pressure (CPAP) at 6 cmHO, a level very frequently used in newborns, alters heart and respiratory rate variability, as well as cardiorespiratory interrelations in a full-term newborn model without lung disease. Moreover, whereas nasal CPAP at 6 cmHO decreases parasympathetic efferent activity, there is no change in sympathetic efferent activity.
本研究旨在进一步阐明新生儿期持续气道正压通气(nCPAP)对心血管和呼吸系统的影响。首先,在 7 只 2-3 天大的健康新生羔羊中进行了 6 小时多导睡眠描记术记录,随机无 nCPAP 应用(nCPAP-6)和 nCPAP-6 应用。使用应用于 ECG 和呼吸记录的半自动信号处理方法分析 nCPAP-6 对心率变异性、呼吸率变异性和心肺相互关系的影响。此后,适应心肺数学模型的实验条件,以获得进一步的生理解释,并模拟更高的 nCPAP 水平(8 和 10 cmHO)。信号处理方法的结果表明,在肺部健康的新生儿中应用 nCPAP-6:)增加心率并降低心率变异性的时间和频域指数,尤其是代表副交感活动的那些,同时增加 RR 间隔时间序列的复杂性;)延长呼吸周期和呼气持续时间并降低呼吸率变异性;)轻微损害心肺相互关系。基于模型的分析表明,nCPAP-6 增加心率并降低呼吸窦性心律失常幅度,同时副交感传出活动减少。当模拟增加的 CPAP 水平时,这些结果更加明显。总体而言,我们的结果提供了对没有肺部疾病的新生儿中 nCPAP 影响的进一步理解。在没有肺部疾病的足月新生儿模型中,应用 6 cmHO 的持续气道正压通气(CPAP)会改变心率和呼吸率变异性以及心肺相互关系。此外,虽然 nCPAP 6 cmHO 降低了副交感传出活动,但交感传出活动没有变化。